Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: Cervical dilatation using Vaginal Misoprostol: After obtaining informed consent, 400 mcg of Misoprostol will be inserted into the posterior fornix of vagina 4 hours prior to Operative h
Sponsors
Jawaharlal Institute of Postgraduate Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Pre menopausal women and women with age >18 years scheduled for Operative hysteroscopic procedures with Mini resectoscope.
Exclusion criteria
Exclusion criteria: Known case of Cervical incompetence and stenosis Contraindication to Misoprostol use like history of severe asthma, glaucoma, preexisting cardiac disease, hypertension or renal failure. Significant uterovaginal prolapse precluding the administration of vaginal tablets. Pelvic inflammatory disease. Genital tract malignancy like Ca cervix, Vulval carcinoma. Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the pre- dilatation cervical width following vaginal Misoprostol Or vaginal Placebo instillation in women undergoing Operative hysteroscopy using a mini resectoscope-21FTimepoint: During Surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the need for further cervical dilatation, complications and side effects following vaginal Misoprostol Or vaginal Placebo instillation in women undergoing Operative hysteroscopy using a mini resectoscope-21FTimepoint: During surgery and 1 hour after surgery. | — |
Countries
India
Contacts
Public ContactDr Murali S
Jawaharlal Institute of Postgraduate Medical Education and Research
Outcome results
None listed